999
Views
3
CrossRef citations to date
0
Altmetric
Articles

Examining the association between stress and antiretroviral therapy adherence among women living with HIV in Toronto, Ontario

, , ORCID Icon, , , , , , , , , , ORCID Icon, & show all
Pages 45-55 | Received 21 Nov 2019, Accepted 28 Apr 2020, Published online: 18 May 2020

References

  • Gifford AL, Bormann JE, Shively MJ, Wright BC, Richman DD, Bozzette SA. Predictors of self-reported adherence and plasma HIV concentrations in patients on multidrug antiretroviral regimens. J Acquir Immune Defic Syndr. 2000;23(5):386–395.
  • Howard AA, Arnsten JH, Lo Y, Vlahov D, et al. A prospective study of adherence and viral load in a large multi-center cohort of HIV-infected women. AIDS. 2002;16(16):2175–2182.
  • Ickovics JR, Cameron A, Zackin R, et al. Consequences and determinants of adherence to antiretroviral medication: results from Adult AIDS Clinical Trials Group protocol 370. Antivir Ther. 2002;7(3):185–193.
  • Mannheimer S, Friedland G, Matts J, Child C, Chesney M, Terry Beirn Community Programs for Clinical Research on AIDS. The consistency of adherence to antiretroviral therapy predicts biologic outcomes for human immunodeficiency virus-infected persons in clinical trials. Clin Infect Dis. 2002;34(8):1115–1121.
  • Bangsberg DR, Ragland K, Monk A, Deeks SG. A single tablet regimen is associated with higher adherence and viral suppression than multiple tablet regimens in HIV + homeless and marginally housed people. AIDS. 2010;24(18):2835–2840.
  • Martin M, Del Cacho E, Codina C, et al. Relationship between adherence level, type of the antiretroviral regimen, and plasma HIV type 1 RNA viral load: a prospective cohort study. AIDS Res Hum Retroviruses. 2008;24(10):1263–1268.
  • Attia S, Egger M, Muller M, Zwahlen M, Low N. Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis. AIDS. 2009;23(11):1397–1404.
  • Graham SM, Holte SE, Peshu NM, et al. Initiation of antiretroviral therapy leads to a rapid decline in cervical and vaginal HIV-1 shedding. AIDS. 2007;21(4):501–507.
  • Anglemyer A, Rutherford GW, Horvath T, Baggaley RC, Egger M, Siegfried N. Antiretroviral therapy for prevention of HIV transmission in HIV-discordant couples. Cochrane Database Syst Rev. 2013;2013(4):CD009153.
  • Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365(6):493–505.
  • Connor EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med. 1994;331(18):1173–1180.
  • Raboud J, Li M, Walmsley S, et al. Once daily dosing improves adherence to antiretroviral therapy. AIDS Behav. 2011;15(7):1397–1409.
  • Holmes WC, Bilker WB, Wang H, Chapman J, Gross R. HIV/AIDS-specific quality of life and adherence to antiretroviral therapy over time. J AIDS. 2007;46(3):323–327.
  • Gonzalez JS, Penedo FJ, Llabre MM, et al. Physical symptoms, beliefs about medications, negative mood, and long-term HIV medication adherence. Ann Behav Med. 2007;34(1):46–55.
  • Gordillo V, del Amo J, Soriano V, Gonzalez-Lahoz J. Sociodemographic and psychological variables influencing adherence to antiretroviral therapy. AIDS. 1999;13(13):1763–1769.
  • Meade CS, Hansen NB, Kochman A, Sikkema KJ. Utilization of medical treatments and adherence to antiretroviral therapy among HIV-positive adults with histories of childhood sexual abuse. AIDS Patient Care STDS. 2009;23(4):259–266.
  • Chesney MA, Ickovics JR, Chambers DB, et al. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG). AIDS Care. 2000;12(3):255–266.
  • Ickovics J, Meade CS. Adherence strategies. Stressful life events have profound impact on ART. Study outlines public health problem. AIDS Alert. 2008;23(6):63–64.
  • Wagner GJ, Bogart LM, Galvan FH, Banks D, Klein DJ. Discrimination as a key mediator of the relationship between posttraumatic stress and HIV treatment adherence among African American men. J Behav Med. 2012;35(1):8–18.
  • King RM, Vidrine DJ, Danysh HE, et al. Factors associated with nonadherence to antiretroviral therapy in HIV-positive smokers. AIDS Patient Care STDS. 2012;26(8):479–485.
  • Leserman J, Ironson G, O’Cleirigh C, Fordiani JM, Balbin E. Stressful life events and adherence in HIV. AIDS Patient Care STDS. 2008;22(5):403–411.
  • Merenstein DJ, Schneider MF, Cox C, et al. Association between living with children and adherence to highly active antiretroviral therapy in the Women’s Interagency HIV Study. Pediatrics. 2008;121(4):e787–93.
  • Merenstein D, Schneider MF, Cox C, et al. Association of child care burden and household composition with adherence to highly active antiretroviral therapy in the Women’s Interagency HIV Study. AIDS Patient Care STDS. 2009;23(4):289–296.
  • Plankey M, Bacchetti P, Jin C, et al. Self-perception of body fat changes and HAART adherence in the Women’s Interagency HIV Study. AIDS Behav. 2009;13(1):53–59.
  • Wilson TE, Barron Y, Cohen M, Richardson J, Greenblatt R, Sacks HS, et al. Adherence to antiretroviral therapy and its association with sexual behavior in a national sample of women with human immunodeficiency virus. Clin Infect Dis. 2002;34(4):529–534.
  • Hanna DB, Hessol NA, Golub ET, et al. Increase in single-tablet regimen use and associated improvements in adherence-related outcomes in HIV-infected women. J AIDS. 2014;65(5):587–596.
  • Dale S, Cohen M, Weber K, Cruise R, Kelso G, Brody L. Abuse and resilience in relation to HAART medication adherence and HIV viral load among women with HIV in the United States. AIDS Patient Care STDS. 2014;28(3):136–143.
  • Kapadia F, Vlahov D, Wu Y, et al. Impact of drug abuse treatment modalities on adherence to ART/HAART among a cohort of HIV seropositive women. Am J Drug Alcohol Abuse. 2008;34(2):161–170.
  • Brody LR, Stokes LR, Kelso GA, et al. Gender role behaviors of high affiliation and low self-silencing predict better adherence to antiretroviral therapy in women with HIV. AIDS Patient Care STDS. 2014;28(9):459–461.
  • Yoong D, Bayoumi AM, Robinson L, Rachlis B, Antoniou T. Public prescription drug plan coverage for antiretrovirals and the potential cost to people living with HIV in Canada: a descriptive study. CMAJO. 2018;6(4):E551–E60.
  • Rachlis B, Light L, Gardner S, et al. The impact of drug coverage on viral suppression among people living with HIV in Ontario. Can J Public Health. 2018;109(5–6):800–809.
  • Baum A. Stress, intrusive imagery, and chronic distress. Health Psychol. 1990;9(6):653–675.
  • Baum A, Posluszny DM. Health psychology: mapping biobehavioral contributions to health and illness. Annu Rev Psychol. 1999;50(1):137–163.
  • Leserman J. Role of depression, stress, and trauma in HIV disease progression. Psychosom Med. 2008;70(5):539–545.
  • Leserman J, Pence BW, Whetten K, et al. Relation of lifetime trauma and depressive symptoms to mortality in HIV. AJP. 2007;164(11):1707–1713.
  • Kendall CE, Shoemaker ES, Boucher L, Rolfe DE, et al. The organizational attributes of HIV care delivery models in Canada: a cross-sectional study. PLoS One. 2018;13(6):e0199395.
  • Rourke SB, Gardner S, Burchell AN, et al. Cohort profile: the Ontario HIV Treatment Network Cohort Study (OCS). Int J Epidemiol. 2013;42(2):402–411.
  • Chesney MA. Factors affecting adherence to antiretroviral therapy. Clin Infect Dis. 2000;30(Suppl 2):S171–S176.
  • Shields M. Stress, health and the benefit of social support. Stat Canada Health Rep. 2004;15(1):9–38.
  • Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Measure. 1977;1(3):385–401.
  • Sheehan TJ, Fifield J, Reisine S, Tennen H. The measurement structure of the Center for Epidemiologic Studies Depression Scale. J Pers Assess. 1995;64(3):507–521.
  • Babor TF, Higgins-Biddle JC, Saunders JB, Monteiro MG. The alcohol use disorders identification test guidelines for primary care. Report No: WHO/MSD/MSB/01.6a. Geneva, Switzerland: World Health Organization; 2001.
  • Ontario Public Health Standards. Appendix A: disease-specific. Chapters: Acquired Immunodeficiency Syndrome (AIDS). Ontario: Ontario Public Health Standards; Infectious Diseases Protocol; Public Health Ontario; 2014. http://www.health.gov.on.ca/en/pro/programs/publichealth/oph_standards/docs/aids_chapter.pdf.
  • Ickovics JR, Meade CS. Adherence to antiretroviral therapy among patients with HIV: a critical link between behavioral and biomedical sciences. J AIDS. 2002;31(Suppl 3):S98–S102.
  • Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000;133(1):21–30.
  • Nilsson Schonnesson L, Diamond PM, Ross MW, Williams M, Bratt G. Baseline predictors of three types of antiretroviral therapy (ART) adherence: a 2-year follow-up. AIDS Care. 2006;18(3):246–253.
  • Nilsson Schonnesson L, Williams ML, Ross MW, Bratt G, Keel B. Factors associated with suboptimal antiretroviral therapy adherence to dose, schedule, and dietary instructions. AIDS Behav. 2007;11(2):175–183.
  • Miller LG, Hays RD. Adherence to combination antiretroviral therapy: synthesis of the literature and clinical implications. AIDS Read. 2000;10(3):177–185.
  • Miller LG, Liu H, Hays RD, et al. Knowledge of antiretroviral regimen dosing and adherence: a longitudinal study. Clin Infect Dis. 2003;36(4):514–518.
  • Holzemer WL, Corless IB, Nokes KM, et al. Predictors of self-reported adherence in persons living with HIV disease. AIDS Patient Care STDS. 1999;13(3):185–197.
  • Singh N, Berman SM, Swindells S, et al. Adherence of human immunodeficiency virus-infected patients to antiretroviral therapy. Clin Infect Dis. 1999;29(4):824–830.
  • Brown DW, Anda RF. Adverse childhood experiences: origins of behaviors that sustain the HIV epidemic. AIDS. 2009;23(16):2231–2233.
  • Monroe SM, Slavich GM, Gotlib IH. Life stress and family history for depression: the moderating role of past depressive episodes. J Psychiatr Res. 2014;49:90–95.
  • Berger-Greenstein JA, Cuevas CA, Brady SM, Trezza G, Richardson MA, Keane TM. Major depression in patients with HIV/AIDS and substance abuse. AIDS Patient Care and STDs. 2007;21(12):942–955.
  • Catz SL, Gore-Felton C, McClure JB. Psychological distress among minority and low-income women living with HIV. Behav Med. 2002;28(2):53–60.
  • Lima VD, Geller J, Bangsberg DR, et al. The effect of adherence on the association between depressive symptoms and mortality among HIV-infected individuals first initiating HAART. AIDS. 2007;21(9):1175–1183.
  • Kacanek D, Jacobson DL, Spiegelman D, Wanke C, Isaac R, Wilson IB. Incident depression symptoms are associated with poorer HAART adherence: a longitudinal analysis from the Nutrition for Healthy Living study. J AIDS. 2010;53(2):266–272.
  • Turner BJ, Laine C, Cosler L, Hauck WW. Relationship of gender, depression, and health care delivery with antiretroviral adherence in HIV-infected drug users. J Gen Intern Med. 2003;18(4):248–257.
  • Malbergier A, Amaral RA, Cardoso LD. Alcohol dependence and CD4 cell count: is there a relationship? AIDS Care. 2015;27(1):54–55.
  • Stockwell T, Zhao J, Macdonald S. Who under-reports their alcohol consumption in telephone surveys and by how much? An application of the “yesterday method” in a national Canadian substance use survey. Addiction. 2014;109(10):1657–1666.
  • Jitnarin N, Heinrich KM, Haddock CK, Hughey J, Berkel L, Poston WS. Neighborhood Environment Perceptions and the Likelihood of Smoking and Alcohol Use. IJERPH. 2015;12(1):784–799.
  • Mendrek A. [Are there any sex/gender differences in drug use and drug addiction?]. SMQ. 2014;39(2):57–74. [in French]
  • Ghebremichael M, Paintsil E, Ickovics JR, et al. Longitudinal association of alcohol use with HIV disease progression and psychological health of women with HIV. AIDS Care. 2009;21(7):834–841.
  • Allen AM, Hay JE. Review article: the management of cirrhosis in women. Aliment Pharmacol Ther. 2014;40(10):1146–1154.
  • Chomistek AK, Chiuve SE, Eliassen AH, Mukamal KJ, Willett WC, Rimm EB. Healthy lifestyle in the primordial prevention of cardiovascular disease among young women. J Am Coll Cardiol. 2015;65(1):43–51.
  • Hutton HE, McCaul ME, Norris J, Valliant JD, Abrefa-Gyan T, Chander G. Sex-related alcohol expectancies among african american women attending an urban STI clinic. J Sex Res. 2015;52:580–519.
  • Liu Y, Nguyen N, Colditz GA. Links between alcohol consumption and breast cancer: a look at the evidence. Womens Health (Lond Engl). 2015;11(1):65–77.
  • Valmas MM, Mosher Ruiz S, Gansler DA, Sawyer KS, Oscar-Berman M. Social cognition deficits and associations with drinking history in alcoholic men and women. Alcohol Clin Exp Res. 2014;38(12):2998–3007.
  • Kendall CE, Wong J, Taljaard M, et al. A cross-sectional, population-based study measuring comorbidity among people living with HIV in Ontario. BMC Publ Health. 2014;14(1):161.
  • Wilson MG, Chambers L, Bacon J, Rueda S, Ragan M, Rourke SB. Issues of Comorbidity in HIV/AIDS: An Overview of Systematic Reviews. Toronto, ON: Ontario HIV Treatment Network; 2010.
  • Jane-Llopis E, Matytsina I. Mental health and alcohol, drugs and tobacco: a review of the comorbidity between mental disorders and the use of alcohol, tobacco and illicit drugs. Drug Alcohol Rev. 2006;25(6):515–536.
  • Burchell AN, Gardner S, Light L, et al. Implementation and operational research: Engagement in HIV care among persons enrolled in a clinical HIV cohort in Ontario, Canada, 2001. J AIDS. 2015;70(1):e10–e19.
  • Bezabhe WM, Chalmers L, Bereznicki LR, Peterson GM. Adherence to antiretroviral therapy and virologic failure: a meta-analysis. Medicine (Baltimore, MD). 2016;95(15):e3361.
  • Cantudo-Cuenca MR, Jimenez-Galan R, Almeida-Gonzalez CV, Morillo-Verdugo R. Concurrent use of comedications reduces adherence to antiretroviral therapy among HIV-infected patients. JMCP. 2014;20(8):844–850.
  • Reinert DF, Allen JP. The alcohol use disorders identification test: an update of research findings. Alcoholism Clin Exp Res. 2007;31(2):185–199.
  • Bradley KA, Bush KR, Epler AJ, et al. Two brief alcohol-screening tests from the Alcohol Use Disorders Identification Test (AUDIT): validation in a female Veterans Affairs patient population. Arch Intern Med. 2003;163(7):821–829.
  • Gache P, Michaud P, Landry U, et al. The Alcohol Use Disorders Identification Test (AUDIT) as a screening tool for excessive drinking in primary care: reliability and validity of a French version. Alcohol Clin Exp Res. 2005;29(11):2001–2007.
  • Neumann T, Neuner B, Gentilello LM, et al. Gender differences in the performance of a computerized version of the alcohol use disorders identification test in subcritically injured patients who are admitted to the emergency department. Alcohol Clin Exp Res. 2004;28(11):1693–1701.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.